Sponsor:
Mayo Clinic
Code:
NCT07126496
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Internet-Based Intervention
Questionnaire Administration
Virtual Technology Intervention
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT07126496
Start date
May 20, 2025
Status verified date
Aug, 2026
Completion date
Aug 31, 2027
Anticipated
Primary completion date
Aug 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
2000 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Health Services Research
Arms
experimental: Arm I (ALEX Research Portal, vCHE)
active comparator: Arm II (online text)
Interventions
Internet-Based Intervention
Questionnaire Administration
Virtual Technology Intervention
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Florida
Recruiting
Jacksonville, Florida, United States, 32224-9980
Contacts
Principal Investigator:
Janice L. Krieger, PhD
Sponsor
Mayo Clinic
Last update posted
Aug 11, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-08-11.